Chaput N - Search Results

1

The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2.

Mignot G, Ullrich E, Bonmort M, Ménard C, Apetoh L, Taieb J, Bosisio D, Sozzani S, Ferrantini M, Schmitz J, Mack M, Ryffel B, Bulfone-Paus S, Zitvogel L, Chaput N. Mignot G, et al. Among authors: chaput n. J Immunol. 2008 May 15;180(10):6477-83. doi: 10.4049/jimmunol.180.10.6477. J Immunol. 2008. PMID: 18453565

2

Biomarkers of response to immunotherapy in early stage non-small cell lung cancer.

Roulleaux Dugage M, Albarrán-Artahona V, Laguna JC, Chaput N, Vignot S, Besse B, Mezquita L, Auclin E. Roulleaux Dugage M, et al. Among authors: chaput n. Eur J Cancer. 2023 May;184:179-196. doi: 10.1016/j.ejca.2023.01.029. Epub 2023 Feb 17. Eur J Cancer. 2023. PMID: 36963241 Review.

3

Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.

Rousseau A, Tagliamento M, Auclin E, Aldea M, Frelaut M, Levy A, Benitez JC, Naltet C, Lavaud P, Botticella A, Grecea M, Chaput N, Barlesi F, Planchard D, Besse B. Rousseau A, et al. Among authors: chaput n. Eur J Cancer. 2023 Mar;182:107-114. doi: 10.1016/j.ejca.2023.01.007. Epub 2023 Jan 13. Eur J Cancer. 2023. PMID: 36758475

4

Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.

Ikarashi Y, Mikami R, Bendelac A, Terme M, Chaput N, Terada M, Tursz T, Angevin E, Lemonnier FA, Wakasugi H, Zitvogel L. Ikarashi Y, et al. Among authors: chaput n. J Exp Med. 2001 Oct 15;194(8):1179-86. doi: 10.1084/jem.194.8.1179. J Exp Med. 2001. PMID: 11602646 Free PMC article.

5

From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes.

Schartz NE, Chaput N, André F, Zitvogel L. Schartz NE, et al. Among authors: chaput n. Curr Opin Mol Ther. 2002 Aug;4(4):372-81. Curr Opin Mol Ther. 2002. PMID: 12222875 Review.

6

Tumor-derived exosomes: a new source of tumor rejection antigens.

André F, Schartz NE, Chaput N, Flament C, Raposo G, Amigorena S, Angevin E, Zitvogel L. André F, et al. Among authors: chaput n. Vaccine. 2002 Dec 19;20 Suppl 4:A28-31. doi: 10.1016/s0264-410x(02)00384-5. Vaccine. 2002. PMID: 12477425 Review.

7

Exosomes for immunotherapy of cancer.

Chaput N, Schartz NE, Andre F, Zitvogel L. Chaput N, et al. Adv Exp Med Biol. 2003;532:215-21. doi: 10.1007/978-1-4615-0081-0_17. Adv Exp Med Biol. 2003. PMID: 12908560 Review.

8

[Exosomes and anti-tumour immunotherapy].

Chaput N, Andre F, Schartz NE, Flament C, Angevin E, Escudier B, Zitvogel L. Chaput N, et al. Bull Cancer. 2003 Aug-Sep;90(8-9):695-8. Bull Cancer. 2003. PMID: 14609758 Free article. Clinical Trial. French.

9

Exosome-based immunotherapy.

Chaput N, Taïeb J, Schartz NE, André F, Angevin E, Zitvogel L. Chaput N, et al. Cancer Immunol Immunother. 2004 Mar;53(3):234-9. doi: 10.1007/s00262-003-0472-x. Epub 2004 Jan 16. Cancer Immunol Immunother. 2004. PMID: 14727085 Free PMC article. Review.

10

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.

André F, Chaput N, Schartz NE, Flament C, Aubert N, Bernard J, Lemonnier F, Raposo G, Escudier B, Hsu DH, Tursz T, Amigorena S, Angevin E, Zitvogel L. André F, et al. Among authors: chaput n. J Immunol. 2004 Feb 15;172(4):2126-36. doi: 10.4049/jimmunol.172.4.2126. J Immunol. 2004. PMID: 14764678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters